Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Microbiome: The Next Frontier in Human Health

By IRP Staff Blogger

Thursday, December 24, 2015

At the beginning of every episode of the sci-fi television series Star Trek, William Shatner repeated the famous phrase, “Space: the final frontier.” However, in all of Star Trek’s 79 episodes, Captain James T. Kirk and crew never encountered anything like the number and diversity of species that exists within the human microbiome, a collection of microorganisms that live everywhere in and on our body and outnumber our cells almost ten to one.

Like the crew of the Starship Enterprise, our scientists must slowly piece together whether these newfound species are friend or foe. And if foe, how they can be overcome, subdued, or convinced to become good guys. As a scientific discipline, understanding the human microbiome is clearly more “sci” than “fi”—but the unfolding story of our symbiotic relationship with microbes in every niche of the human body currently reads more like it came from the world of fiction.

The latest research in this area suggests that our relationship with these microbes is essential to maintaining good health and that dysregulation of the microbiome is associated with disease. By analyzing the collective genome of the microbes in their natural environment—a field known as metagenomics—our scientists are discovering that the microbiome may have untapped potential to be manipulated in ways that might treat or even cure diseases.

In 2008, the IRP was part of an NIH-wide five-year initiative to analyze the microbiome and its role in human health and disease called the Human Microbiome Project (HMP). It showed us that the microbiome is far from isolated to just the gut, and includes the skin, mouth, intestines, nose, and genitals, all of which have unique microbial profiles that are essential to maintaining the health of those body parts.

IRP researchers continue to build upon those findings:

  • Heidi Kong, M.D., M.H.Sc., uncovered major differences in the skin microbiome between patients with eczema and healthy subjects, suggesting that an imbalance in microbial diversity may contribute to disease.
  • The immunoepidemiology lab of James Goedert, M.D., has launched a study to investigate what role the fecal microbiome may have on the development of cancer.
  • Niki Moutsopoulos, D.D.S., Ph.D., and team are investigating what impact the oral microbiome may have on chronic oral inflammatory conditions.

The HMP was so successful in characterizing the thousands of microbial communities coexisting on our bodies that, in 2013, the NIH launched a second phase of the project: the Integrative Human Microbiome Project (iHMP). The iHMP will collect datasets from three different microbiome populations to further characterize biological properties of the microbiome in a natural environment and in disease states, including pre-term birth, inflammatory bowel disease, and prediabetes. These massively complicated datasets are mined using state-of-the-art, high-throughput computers that—like the IRP model of collaboration and shared resources—are connected through an interdisciplinary effort between teams of investigators at different academic institutions.

The ultimate goal of the iHMP is to understand how a healthy microbiome functions over time and how changes in the biome can lead to disease. It’s the job of our researchers, like the crew of the Starship Enterprise, to “explore strange new worlds, to seek out new life… and to boldly go where no man has gone before.” Ok, that last bit may be a bit of a stretch, but it’s certainly not hyperbole to say that the microbiome is the next major frontier of health science.

In the video below, take a peek into the lab of Yasmine Belkaid, Ph.D., whose IRP team explores the fine balance that exists between microbes and their hosts:


Category: IRP Life
Tags: microbiome, bacteria, yeast, fungi, Star Trek, Human Microbiome Project, gut, skin, mouth, intestines, nose, genitals

Related Blog Posts

  • Six Paths Forward in Biomedical Research
  • Yasmine Belkaid Wins Sanofi–Institut Pasteur 2016 Award
  • A New Understanding of What’s Living on Your Skin
  • IRP’s Julie Segre Elected to the National Academy of Medicine
  • Mouth Microbes Turn Treasonous in Gum Disease

This page was last updated on Thursday, January 4, 2024

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search